Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
HK:2696
Stock Latest News
Company Announcements
Henlius Wins Key EMA Backing for Serplulimab Lung Cancer Use
19h ago
2696
Premium
Company Announcements
Henlius Begins First-in-Human Trial of First-in-Class B7-H3 Cancer Fusion Protein
1d ago
2696
Premium
Company Announcements
Henlius Wins NMPA Nod for First-in-Human Trial of Bispecific ADC HLX48
2d ago
2696
Premium
Company Announcements
Henlius Wins Australian Nod to Start First-in-Class Trispecific Antibody Trial for Advanced Prostate Cancer
2d ago
2696
Premium
Company Announcements
Henlius Doses First EU Patient in Global Phase 2 Trial of HLX43 for Advanced Lung Cancer
2d ago
2696
Premium
Company Announcements
Henlius Shareholders Unanimously Approve 2025 Reports and Profit Distribution
4d ago
2696
Premium
Company Announcements
Henlius Wins Australian Nod for First-in-Class Bispecific Cancer ADC Trial
10d ago
2696
Premium
Company Announcements
Henlius Starts First-in-Human Trial of Novel KAT6A/B Inhibitor HLX97 in Advanced Tumours
10d ago
2696
Premium
Company Announcements
Henlius Wins EU Approval for Two New Serplulimab Cancer Uses
13d ago
2696
Premium
Company Announcements
Henlius Wins FDA Nod to Begin U.S. Trial of Cetuximab Biosimilar HLX05-N
13d ago
2696
Premium
Company Announcements
Henlius Wins Japan Go-Ahead for Global Phase 2/3 Trial of Lung Cancer ADC HLX43
19d ago
2696
Premium
Company Announcements
Henlius Starts First-in-Human Trial of Novel Tetra-Specific Cancer Antibody HLX3901
23d ago
2696
Premium
Company Announcements
Henlius Wins EU Nod for Pertuzumab Biosimilar, Expanding Global Oncology Footprint
25d ago
2696
Premium
Company Announcements
Henlius wins Australian nod for global phase 2/3 trial of HLX07 combo in advanced lung cancer
29d ago
2696
Premium
Company Announcements
Henlius Sets 2026 AGM to Approve 2025 Results and New Share Issuance Mandate
29d ago
2696
Premium
Company Announcements
Henlius Grants New Share Options and RSUs to Align Incentives With Performance
1M ago
2696
Premium
Company Announcements
Henlius Wins NMPA Nod to Start Trials of Cetuximab Biosimilar HLX05-N
1M ago
2696
Premium
Company Announcements
Henlius Starts Phase 1 Trial of HLX319, a Subcutaneous Pertuzumab-Trastuzumab Biosimilar in China
1M ago
2696
Premium
Company Announcements
Henlius Wins China Nod to Expand Indications for Rituximab Biosimilar HANLIKANG
1M ago
2696
Premium
Company Announcements
Henlius Wins NMPA Nod to Begin Trials of HER2 Breast Cancer Biosimilar HLX319
2M ago
2696
Premium
Company Announcements
Henlius Wins NMPA Nod to Start Trials of Novel Hyaluronidase Injection
2M ago
2696
Premium
Company Announcements
Henlius Wins Key EMA Backing for Cancer Drug Serplulimab in Europe
2M ago
2696
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
